Brief: Todos Medical Announces Positive Initial Clinical Proof Of Concept Data For A Rapid SARS-CoV-2 3CL Protease Detection Assay
18/11/2020 13:55
Nov 18 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL ANNOUNCES POSITIVE INITIAL CLINICAL
PROOF-OF-CONCEPT DATA FOR A RAPID SARS-COV-2 3CL PROTEASE
DETECTION ASSAY
Source text for Eikon: ID:nGNX3SdBJD
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities